Dr. Shohet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 774-441-8083Fax+1 774-441-8057
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1995 - 1996
- Baylor College of Medicine (Houston)Residency, Pediatrics, 1993 - 1995
- Boston University School of MedicineClass of 1993
Certifications & Licensure
- MA State Medical License 1999 - 2026
- ME State Medical License 2023 - 2025
- TX State Medical License 2000 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsLongitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation.Alan Van Goethem, Jill Deleu, Nurten Yigit, Celine Everaert, Myrthala Moreno-Smith
NAR Cancer. 2023-03-01 - 21 citationsKDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.Alexandra D'Oto, Jie Fang, Hongjian Jin, Beisi Xu, Shivendra Singh
Nature Communications. 2021-12-10 - 11 citationsSystematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.Esteban Javier Rozen, Jason Matthew Shohet
Cancer Metastasis Reviews. 2021-10-30
Other
- Clinical presentation, diagnosis, and staging evaluation of neuroblastomaShohet JM, Russell HV, Nuchtern JG
http://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-evaluation-of-neuroblas
UpToDate, Wolters Kluwer Health - 2012-05-30 - Epidemiology, pathogenesis, and pathology of neuroblastomaShohet JM, Russell HV, Nuchtern JG
http://www.uptodate.com/contents/epidemiology-pathogenesis-and-pathology-of-neuroblastoma
UpToDate, Wolters Kluwer Health - 2012-05-29 - Treatment and prognosis of neuroblastomaShohet JM, Russell HV, Nuchtern JG
http://www.uptodate.com/contents/treatment-and-prognosis-of-neuroblastoma
UpToDate, Wolters Kluwer Health - 2013-03-27
Press Mentions
- An ALYREF-MYCN Coactivator Complex Drives Neuroblastoma Tumorigenesis Through Effects on USP3 and MYCN StabilityMarch 25th, 2021
- A Novel Combination Therapy Targeting Ubiquitin-Specific Protease 5 in MYCN-Driven NeuroblastomaMarch 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: